Tocofersolan
As of the edition of 20 October 2026, Tocofersolan is a small molecule: marketed, first approved in 2009 (EU).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2009
- Kind
- Small molecule
- Brand name
- Vedrop
- First approved
- 23 July 2009 (EU)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Recordati Rare Diseases
- Registered trials
- 4, 1 stopped early
- Disease areas
- Infections; Nutrition and metabolism; Digestive system; Inherited and neonatal
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 2 | 2 | 0 | 0 |
| Phase 2 | 1 | 0 | 0 | 1 |
| Phase 3 | 1 | 1 | 0 | 0 |
| All trials | 4 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Recordati Rare Diseases | Applicant | 2009 to now |